Improving Pediatric Growth Outcomes: The Impact of Moringa Oleifera Seed Supplementation on Undernourished Populations

EFFECTS OF MORINGA OLEIFERA SEED SUPPLEMENTATION ON GROWTH PARAMETERS AMONG THE UNDERNOURISHED PEDIATRIC POPULATION - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/066149

Enrollment

Registered

2024-04-23

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Moringa oleifera Seed: Moringa oleifera seed incorporated in a Sattu Maavu (Health Mix) Will be supplemented as a snack product, NutriBar 100g of product will be given daily for 6m

Eligibility

Inclusion criteria

Inclusion criteria: Individual who is only malnourished, should not have any co-morbidities or congential anomalies and not on any medication.

Exclusion criteria

Exclusion criteria: Children with any co-morbidities or congential anomalies, and not on any medications will be excluded

Design outcomes

Primary

Measure	Time frame
The primary outcome is to recognise the effect in the STAMP scoring, which includes growth parameters of height and weight using WHO’s growth chart (dependent variable).Timepoint: The primary outcome is to recognise the effect in the STAMP scoring, which includes growth parameters of height and weight using WHO’s growth chart (dependent variable). Baseline assessment will be assessed before the study, during (3month) and at the end of the study.	—

Measure

Time frame

The primary outcome is to recognise the effect in the STAMP scoring, which includes growth parameters of height and weight using WHO’s growth chart (dependent variable).Timepoint: The primary outcome is to recognise the effect in the STAMP scoring, which includes growth parameters of height and weight using WHO’s growth chart (dependent variable). Baseline assessment will be assessed before the study, during (3month) and at the end of the study.

—

Secondary

Measure	Time frame
The secondary outcomes are to recognise the effect in the, ? anthropometric measures (weight for age, weight for height and BMI for age) according to the WHO’s growth standards, ? body composition analysis (BMI, MAC, BMR, body fat, bone mass, and muscle mass) and oxidative stress bio marker, serum malondialdehyde test. ? blood parameters (haemoglobin, albumin, BUN & Creatinine), which will be monitored at the baseline, during (3months) and at end of the study. Timepoint: ? a dietary recall will be collected 15 days once to monitor their regular dietary intake during the study period.	—

Measure

Time frame

The secondary outcomes are to recognise the effect in the, ? anthropometric measures (weight for age, weight for height and BMI for age) according to the WHO’s growth standards, ? body composition analysis (BMI, MAC, BMR, body fat, bone mass, and muscle mass) and oxidative stress bio marker, serum malondialdehyde test. ? blood parameters (haemoglobin, albumin, BUN & Creatinine), which will be monitored at the baseline, during (3months) and at end of the study. Timepoint: ? a dietary recall will be collected 15 days once to monitor their regular dietary intake during the study period.

—

Countries

India

Contacts

Public ContactAnusha K

Sri Ramachandra Institute of Higher Education and Research, (DU)

gayathri.g@sriramachandra.edu.in9566226255

Outcome results